Passage Bio
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$102,062,000 over the previous period. Total operating expenses were $108,389,000.

Profit Margin

Passage Bio, Inc. (NASDAQ:PASG): Profit margin
2018 0 -12.77M
2019 0 -54.57M
2020 0 -111.76M
2021 0 -191.5M
2022 0 -136.85M
2023 0 -102.06M

PASG Income Statement (2018 – 2023)

2023 2022 2021 2020 2019 2018
Revenue
Revenue
000000
Cost of revenue
3.72M3.67M1.54M800K134K0
Gross profit
-3.72M-3.67M-1.54M-800K-134K0
Operating exp.
Research and development
61.41M86.05M117.67M81.78M29.73M9.16M
Selling and marketing
000000
Total operating expenses
108.38M135.39M177.72M111.90M36.68M10.09M
Operating income
-108.38M-138.39M-185.72M-112.90M-37.18M-13.46M
Other income (expenses), net
6.32M2.26M343K670K-8.44M-2.67M
Income before tax
-102.06M-136.12M-185.38M-112.23M-45.63M-12.77M
Income tax expense
0731K6.11M-470K8.94M-696K
Net income
-102.06M-136.85M-191.5M-111.76M-54.57M-12.77M
Earnings per share
Basic EPS
-1.86-2.51-3.59-2.89-1.19-0.53
Diluted EPS
-1.86-2.51-3.59-2.89-1.19-0.53
Data sourceData sourceData sourceData source